Beyond Air Enters Distribution Agreement with Getz Healthcare for LungFit PH in Asia-Pacific

Beyond Air, Inc.

Getz Healthcare to make $1,000,000 milestone payment upon CE mark certification of LungFit PH in Europe.
Beyond Air receives ongoing royalty payments on net sales starting at low double-digits and peaking at 20%.
Partnership covers 10 Asia-Pacific countries including Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore, and Vietnam.
BTIG, LLC acted as financial advisor to Beyond Air for the agreement.
LungFit PH is currently FDA-approved for neonates with hypoxic respiratory failure in the U.S. only.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.